Black Diamond Therapeutics
BDTX
BDTX
91 hedge funds and large institutions have $147M invested in Black Diamond Therapeutics in 2025 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 23
2% less funds holding
Funds holding: 93 → 91 (-2)
Holders
91
Holding in Top 10
–
Calls
$450K
Puts
$17K
Top Buyers
| 1 | +$2.88M | |
| 2 | +$2.13M | |
| 3 | +$1.82M | |
| 4 |
Renaissance Technologies
New York
|
+$1.64M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.28M |
Top Sellers
| 1 | -$6.78M | |
| 2 | -$804K | |
| 3 | -$740K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$621K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$459K |
